ACS PRF | ACS | All e-Annual Reports

Reports: AC1

Back to Table of Contents

47272-AC1
Short, Tunable Chiral Peptidic Ligands for Osmium Tetroxide-Mediated Chemistry

Babak Borhan, Michigan State University

In sharp contrast to the large number of known examples of substrate controlled stereoselective halolactonizations, reagent controlled processes are exceptionally rare, and have only begun to emerge within the last 15 to 20 years.  The advantages of a successful approach to a reagent controlled halolactonization are obvious, since such a methodology would provide rapid access to richly functionalized halolactones in one step from achiral congeners.  Utilizing the funds from PRF, we have initiated a comprehensive research program that is charged with evaluating new asymmetric catalytic systems that are obtained easily and can be rapidly synthesized and screened.  These include peptidic scaffolds and non-peptidic motifs (at times a mix of the latter two systems).  In particular, we will evaluate these chemistries via the OsO4 mediate oxidation of olefins and the halolactonization reactions of hydroxyalkenes.

Preliminary experiments have uncovered a viable, selective Cinchona alkaloid based organocatalyst for the chlorolactonization of 4-arylpentenoic acids (Figure 1).  In the presence of only 10 mol % of (DHQD)2PHAL, alkenoic acid 1 is cyclized to give chloro-g-lactone 2 in high yield and 83% ee, thus establishing a quaternary chiral center.  Central to the success of this approach was the optimization of both solvent and halogen source.  Chloroform was found to be ideal, with other solvents providing substantially reduced selectivities.  The choice of 1,3-dichloro-5,5-dimethylhydantoin (3) as the halogen source proved to be crucial to provide the highest selectivities.  Chlorination by action of N-chlorosuccinimide (NCS) returned chlorolactone 2 with reduced ee (65%), while bromolactonization with NBS returned the corresponding bromolactone with 35% ee.  An exhaustive screen of other commercially available Cinchona alkaloids and derivatives thereof confirmed (DHQD)2PHAL as the optimal catalyst.  Figure 1 illustrates the screening of other chlorohydantoins and the %ee's afford by each for the preparation of 2.  The next step is to screen a number of peptidic scaffolds such as 8 to investigate whether or not they are capable of inducing asymmetry in the aforementioned reaction.  To date, we have synthesized over 20 peptides that will be screened under different reaction conditions for the latter purpose.

During the course of our investigation of the Cinchona alkaloid mediated enantioselective chlorolactonization protocol, we sought a general and operationally simple methodology for preparing various N-chlorinated hydantoins.  N-chlorohydantoins, most notably 1,3-dichloro-5,5-dimethylhydantoin (DCDMH, 3), have been used as electrophilic chlorine sources and oxidants in a number of transfomations.  We have recently disclosed a simple methodology for the preparation of N-chlorohydantoins (10) by treatment of the hydantoin starting materials (9) with trichloroisocyanuric acid (TCCA, 11).  Ten examples were prepared in high yield, relying on a simple recrystallization as the only purification step (Figure 2).  An important benefit of this methodology is that for the first time, chiral N-chlorohydantoins have been prepared in high yield and enantiopurity.  These compounds are readily available by the TCCA mediated chlorination of the corresponding chiral hydantoin substrates, which are in turn easily prepared by known methodology from their chiral a-amino acid or amide congeners.  We were also able to demonstrate that the chlorination event and subsequent dechlorination (by action of saturated aqueous sodium sulfite) proceeds without erosion of enantioselectivity.  We will pursue experiments aimed at the development of N-chlorohydantoins as reagents for asymmetric chlorination reactions. 

In 2002, Braddock and coworkers disclosed an effective catalyst for the bromolactonization of olefinic carboxylic acids employing ortho-iodoarylamide (e.g. 14) and amidine (e.g. 15) catalysts in the presence of N-bromosuccinimide (NBS).  These catalysts, shown to proceed via an iodine (I)/iodine (III) oxidative couple (16), showed a significant increase in rate relative to the uncatalyzed reaction with NBS alone (Figure 3). Subsequently, they reported that a similar rate acceleration could be accomplished by employing non-iodinated amidines.  We surmised that incorporating this general catalyst scaffold within a chiral peptide framework might garner some selectivity in the process.  With this in mind, we have prepared and evaluated roughly 40 peptides for the asymmetric bromolactonization of compound 17.  The preparation of such catalysts is facilitated by Fmoc solid phase peptide synthesis (SPPS).  Importantly, we have discovered an initial "hit" scaffold that returns the desired bromolactone 19 in 14% ee when 0.1 equivalents of peptide 18 is employed.  It is likely that continued exploration of the "chiral space" about this promising scaffold, available through natural and unnatural amino acid building blocks will lead to an optimized catalyst.  Such combinatorial approaches driven by directed screening about an initial "hit" scaffold is a proven strategy for catalyst design.

Back to top